anmelden
SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.06.21 | Roche Outperform | Bernstein Research | |
| 29.06.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 28.06.21 | Roche Hold | Deutsche Bank AG | |
| 25.06.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.06.21 | Novartis Hold | Kepler Cheuvreux | |
| 17.06.21 | Roche Hold | Deutsche Bank AG | |
| 17.06.21 | Novartis buy | Deutsche Bank AG | |
| 15.06.21 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.06.21 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.06.21 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.06.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.06.21 | Roche Equal-Weight | Morgan Stanley | |
| 09.06.21 | Roche Hold | Jefferies & Company Inc. | |
| 08.06.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.06.21 | Novartis Neutral | Credit Suisse Group | |
| 07.06.21 | Roche Neutral | Credit Suisse Group | |
| 04.06.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.06.21 | Novartis buy | UBS AG | |
| 04.06.21 | Novartis buy | Jefferies & Company Inc. | |
| 21.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.05.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 20.05.21 | Roche Outperform | Bernstein Research | |
| 20.05.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 19.05.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 19.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.05.21 | Novartis buy | Deutsche Bank AG | |
| 14.05.21 | Novartis buy | UBS AG | |
| 11.05.21 | Novartis buy | Deutsche Bank AG | |
| 10.05.21 | Novartis buy | UBS AG | |
| 30.04.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.04.21 | Novartis buy | Deutsche Bank AG | |
| 28.04.21 | Novartis Underweight | Barclays Capital | |
| 28.04.21 | Novartis Neutral | Credit Suisse Group | |
| 28.04.21 | Novartis buy | Deutsche Bank AG | |
| 28.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.04.21 | Novartis buy | Jefferies & Company Inc. | |
| 27.04.21 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.04.21 | Novartis Underweight | Barclays Capital | |
| 27.04.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. |